NeuraMatrix
PrivateLast Round
Series A
Nov 23, 2021
Total Funding Raised
$15.65M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NeuraMatrix operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series A round in November 2021.
NeuraMatrix is a biotechnology company that develops implantable neural interfaces and brain-machine interface (BMI) technology for neuroscience research and clinical applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Computing Hardware, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuraMatrix Comparables
Compare NeuraMatrix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BCIFlex | 90% | |
| NeuCyber NeuroTech (Beijing) Co., Ltd. | 89% | |
| NeuroXess | 86% |
For institutional investors. Book with your work email.
NeuraMatrix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 23, 2021 | ||||
| VC Round | Mar 15, 2021 | ||||
| Angel | Nov 14, 2019 |
For institutional investors. Book with your work email.
NeuraMatrix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ZhenFund | Angel |
| MPC | Series A, VC Round |
| MiraclePlus | Angel |
| Huagai Capital | Series A |
| Cyber Creation Ventures | Angel |
| Tsinghua Holdings Co., Ltd. | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 117% MoM.
- Jul 25, 2026
Monthly visitors increased 602% MoM, from 58 to 407.
For institutional investors. Book with your work email.
NeuraMatrix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuraMatrix's valuation, stock price, and market status.
Is NeuraMatrix a public or private company?
NeuraMatrix is a private company.
What is the current stock price of NeuraMatrix?
NeuraMatrix is a private company, so its shares have no public market price. Caplight tracks NeuraMatrix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuraMatrix worth (valuation)?
Valuation information for NeuraMatrix is not publicly available.
Can I buy NeuraMatrix stock?
NeuraMatrix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuraMatrix's last funding round?
NeuraMatrix's most recent funding round was Series A on November 23, 2021.
Who are the main investors in NeuraMatrix?
Key investors in NeuraMatrix include MPC, Huagai Capital.
Will NeuraMatrix IPO soon?
No public IPO plans have been announced for NeuraMatrix.
How can I track NeuraMatrix secondary market activity?
Caplight tracks bids, offers, and trades in NeuraMatrix's shares on secondary markets.